🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Clinical trial phase I, randomized, double blind, where 30 individuals will...
Status
Completed
Location
Unidade de Ensaios Clínicos para Imunobiológicos
Start Date
2014-05
Trial ID
NCT01889836
Treatments Being Tested
This study will evaluate the safety and immunogenicity of GSK Biologicals' ...
Status
Terminated
Location
GSK Investigational Site
Start Date
2009-04-01
Trial ID
NCT00871741
Treatments Being Tested
This study will evaluate the safety and immunogenicity of GSK Biologicals' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-08-13
Trial ID
NCT00970307
Treatments Being Tested
The purpose of this study is to evaluate immunogenicity and safety of menin...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-07-01
Trial ID
NCT01144663
Treatments Being Tested
The study will include groups of adults, toddlers, and infants who will rec...
Status
Completed
Location
Multiple Locations
Start Date
2006-07-25
Trial ID
NCT06165276
The purpose of this study is to determine when a memory immune response aft...
Status
Unknown
Location
University of Oxford, The Oxford Vaccine Group
Start Date
2003-09
Trial ID
NCT00262015
Treatments Being Tested
This purpose of the study is to assess the safety and immunogenicity of a G...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-07-07
Trial ID
NCT01098474
Treatments Being Tested
The current trial will evaluate the safety and immunogenicity of GSK Biolog...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-08-18
Trial ID
NCT01171989
Treatments Being Tested
This study evaluated the safety and immunogenicity of 3 formulations of Hib...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-03-01
Trial ID
NCT00127855
The primary objectives of this study are to evaluate the immunogenicity and...
Status
Completed
Location
Multiple Locations
Start Date
2012-03-30
Trial ID
NCT01553279
Treatments Being Tested